Latest News

Getting caught up in the numbers of cases we’re reviewing may increase stress and inhibit our productivity.

Catch up on the top radiology content of the past week.

Noting the rising imaging volume and dearth of MRI scanner availability, the authors of a new literature review explore the utility and impact of workflow redesign, staff training, scheduling improvements and AI advances for enhancing MRI workflows.

Smaller voxel size may offer insights into biology we could never access with conventional resolution.

Catch up on the latest episodes of our Breast Imaging in Focus series with Manisha Bahl, MD, MPH, FSBI, discussing research on a variety of topics including breast arterial calcification on mammograms, automated breast ultrasound, AI and GLP-1 receptor agonists.

In a recently published review of the BI-RADS v2025 manual, leading breast radiologists offered pertinent insights on key changes for reporting of mammogram, breast ultrasound and breast MRI interpretation and assessment.

In a recent interview, Kay Jann, PhD, discussed challenges with urinary continence in stroke survivors and a forthcoming NIH-funded study examining the use of brain MRI to help identify those who may benefit from transcutaneous spinal cord stimulation (TSCS).

In comparison to 2023 statistics, the authors of a new study noted an approximately 49 percent increase in radiology turnaround time for ultrasound interpretation and over a 35 percent increase in turnaround time for X-ray assessments.

Extracellular volume fraction (ECV) assessment with photon-counting CT offered higher sensitivity and comparable specificity and AUC to magnetic resonance elastography (MRE)-derived liver stiffness measurement (LSM) for evaluating patients with stage 2 or higher fibrosis, according to a recent study.

The AI tools for the newly launched Invenia ABUS Prime ultrasound platform reportedly facilitate a 40 percent increase in scan speed and up to a 93 percent sensitivity rate for lesion detection in women with dense breasts.

While the vague “R/O pathology” has become pervasive filler for clinical history on requests for imaging, a new wave of clinical histories offer a word salad approach that offers equally little insight into the possible ailment of the patient.

Catch up on the top radiology content of the past week.

Based on results from the phase III PSMAddition trial, the expanded approval may nearly double the number of patients with prostate cancer who can be treated with Pluvicto.